Xeljanz Tablet, Extended Release
Product Images NDC 63539-501
Product Visual Gallery
This gallery contains 29 technical images submitted to the FDA as part of the official labeling for Xeljanz (NDC 63539-501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by U.s. Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Xeljanz 02)
Figure 2 (Xeljanz 03)
Figure 3 (Xeljanz 04)
Figure 4 (Xeljanz 05)
Figure 5 (Xeljanz 06)
Figure 6 (Xeljanz 06a)
Figure 7 (Xeljanz 07)
Logo (Xeljanz 08)
Logo (Xeljanz 09)
Image (Xeljanz 10)
Step 1 (Xeljanz 11)
Step 2 (Xeljanz 12)
Step 3 (Xeljanz 13)
Step 4 (Xeljanz 14)
Step 5 (Xeljanz 15)
Step 6 (Xeljanz 16)
Step 7 (Xeljanz 17)
Step 8 (Xeljanz 18)
Step 9 (Xeljanz 19)
Step 10 (Xeljanz 20)
Step 11 (Xeljanz 21)
Logo (Xeljanz 22)
Principal Display Panel (5 mg Tablet Bottle Label)
Principal Display Panel (11 mg Tablet Bottle Label)
Principal Display Panel (10 mg Tablet Bottle Label)
Principal Display Panel (22 mg Tablet Bottle Label)
Principal Display Panel (240 mL Bottle Label)
Principal Display Panel (240 mL Bottle Carton)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.